Effects of visceral adiposity on glycerol pathways in gluconeogenesis

Metabolism: Clinical and Experimental

Volumn 67, Issue , 2017, Pages 80-89

  Neeland, Ian J ^a   Hughes, Connor ^a   Ayers, Colby R ^b   Malloy, Craig R ^a   Jin, Eunsook S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Gluconeogenesis; Glycerol; Pentose phosphate pathway; Tricarboxylic acid cycle; Visceral fat

Indexed keywords

CARBON 13; GLUCOSE; GLYCEROL; TRICARBOXYLIC ACID; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARBON NUCLEAR MAGNETIC RESONANCE; CITRIC ACID CYCLE; CLINICAL ARTICLE; DIET RESTRICTION; DILUTION; FEASIBILITY STUDY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; IN VIVO STUDY; INTRAPERITONEAL FAT; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PENTOSE PHOSPHATE CYCLE; PILOT STUDY; PRIORITY JOURNAL; REFEEDING; ADIPOSE TISSUE; AGED; ANALYSIS; EATING; FEMALE; INTRAABDOMINAL FAT; MALE; METABOLISM; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CITRIC ACID CYCLE; DIABETES MELLITUS, TYPE 2; EATING; FASTING; FEMALE; GLUCONEOGENESIS; GLYCEROL; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; PENTOSE PHOSPHATE PATHWAY;

EID: 85007007328     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.11.008     Document Type: Article

References (37)

1. [1] Bray, G.A., Jablonski, K.A., Fujimoto, W.Y., Barrett-Connor, E., Haffner, S., Hanson, R.L., et al. Relation of central adiposity and body mass index to the development of diabetes in the diabetes prevention program. Am J Clin Nutr 87 (2008), 1212–1218.
2. [2] Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133 (2007), 496–506.
3. [3] Despres, J.P., Is visceral obesity the cause of the metabolic syndrome?. Ann Med 38 (2006), 52–63.
4. [4] Neeland, I.J., Turer, A.T., Ayers, C.R., Powell-Wiley, T.M., Vega, G.L., Farzaneh-Far, R., et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308 (2012), 1150–1159.
5. [5] Neeland, I.J., Ayers, C.R., Rohatgi, A.K., Turer, A.T., Berry, J.D., Das, S.R., et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring) 21 (2013), E439–E447.
6. [6] Abate, N., Garg, A., Peshock, R.M., Stray-Gundersen, J., Grundy, S.M., Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96 (1995), 88–98.
7. [7] Kuriyama, H., Shimomura, I., Kishida, K., Kondo, H., Furuyama, N., Nishizawa, H., et al. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes 51 (2002), 2915–2921.
8. [8] Nielsen, S., Guo, Z., Johnson, C.M., Hensrud, D.D., Jensen, M.D., Splanchnic lipolysis in human obesity. J Clin Invest 113 (2004), 1582–1588.
9. [9] Baba, H., Zhang, X.J., Wolfe, R.R., Glycerol gluconeogenesis in fasting humans. Nutrition 11 (1995), 149–153.
10. [10] Jin, E.S., Jones, J.G., Merritt, M., Burgess, S.C., Malloy, C.R., Sherry, A.D., Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance analysis of a single glucose derivative. Anal Biochem 327 (2004), 149–155.
11. [11] Jones, J.G., Solomon, M.A., Cole, S.M., Sherry, A.D., Malloy, C.R., An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans. Am J Physiol Endocrinol Metab 281 (2001), E848–E856.
12. [12] Bjorkman, O., Felig, P., Wahren, J., The contrasting responses of splanchnic and renal glucose output to gluconeogenic substrates and to hypoglucagonemia in 60-h-fasted humans. Diabetes 29 (1980), 610–616.
13. [13] Wahren, J., Efendic, S., Luft, R., Hagenfeldt, L., Bjorkman, O., Felig, P., Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans. J Clin Invest 59 (1977), 299–307.
14. [14] Hellerstein, M.K., Neese, R.A., Linfoot, P., Christiansen, M., Turner, S., Letscher, A., Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. J Clin Invest 100 (1997), 1305–1319.
15. [15] Teng, C.T., Karnovsky, M.L., Landau, B.R., Hastings, A.B., Nesbett, F.B., Metabolism of C14-labeled glycerol and pyruvate by liver in vitro. J Biol Chem 202 (1953), 705–716.
16. [16] Previs, S.F., Fernandez, C.A., Yang, D., Soloviev, M.V., David, F., Brunengraber, H., Limitations of the mass isotopomer distribution analysis of glucose to study gluconeogenesis. Substrate cycling between glycerol and triose phosphates in liver. J Biol Chem 270 (1995), 19806–19815.
17. [17] Jin, E.S., Sherry, A.D., Malloy, C.R., Interaction between the pentose phosphate pathway and gluconeogenesis from glycerol in the liver. J Biol Chem 289 (2014), 32593–32603.
18. [18] Jin, E.S., Sherry, A.D., Malloy, C.R., An oral load of [13C3]glycerol and blood NMR analysis detect fatty acid esterification, pentose phosphate pathway and glycerol metabolism through the tricarboxylic acid cycle in human liver. J Biol Chem 291 (2016), 19031–19041.
19. [19] Phillips, J.W., Jones, M.E., Berry, M.N., Implications of the simultaneous occurrence of hepatic glycolysis from glucose and gluconeogenesis from glycerol. Eur J Biochem 269 (2002), 792–797.
20. [20] Moreno, K.X., Satapati, S., DeBerardinis, R.J., Burgess, S.C., Malloy, C.R., Merritt, M.E., Real-time detection of hepatic gluconeogenic and glycogenolytic states using hyperpolarized [2-13C]dihydroxyacetone. J Biol Chem 289 (2014), 35859–35867.
21. [21] Coggan, A.R., Use of stable isotopes to study carbohydrate and fat metabolism at the whole-body level. Proc Nutr Soc 58 (1999), 953–961.
22. [22] Victor, R.G., Haley, R.W., Willett, D.L., Peshock, R.M., Vaeth, P.C., Leonard, D., et al. The Dallas heart study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 93 (2004), 1473–1480.
23. [23] Kaul, S., Rothney, M.P., Peters, D.M., Wacker, W.K., Davis, C.E., Shapiro, M.D., et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring) 20 (2012), 1313–1318.
24. [24] Abate, N., Garg, A., Coleman, R., Grundy, S.M., Peshock, R.M., Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr 65 (1997), 403–408.
25. [25] Neeland, I.J., Grundy, S.M., Li, X., Adams-Huet, B., Vega, G.L., Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas heart study. Nutr Diabetes, 6, 2016, e221.
26. [26] Jin, E.S., Szuszkiewicz-Garcia, M., Browning, J.D., Baxter, J.D., Abate, N., Malloy, C.R., Influence of liver triglycerides on suppression of glucose production by insulin in men. J Clin Endocrinol Metab 100 (2015), 235–243.
27. [27] Landau, B.R., Wahren, J., Chandramouli, V., Schumann, W.C., Ekberg, K., Kalhan, S.C., Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98 (1996), 378–385.
28. [28] Alves, T.C., Nunes, P.M., Palmeira, C.M., Jones, J.G., Carvalho, R.A., Estimating gluconeogenesis by NMR isotopomer distribution analysis of [13C]bicarbonate and [1-13C]lactate. NMR Biomed 21 (2008), 337–344.
29. [29] Jones, J.G., Solomon, M.A., Sherry, A.D., Jeffrey, F.M., Malloy, C.R., 13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C]propionate, phenylacetate, and acetaminophen. Am J Physiol 275 (1998), E843–E852.
30. [30] Kato, T., Hayashi, Y., Inoue, K., Yuasa, H., Glycerol absorption by Na + − dependent carrier-mediated transport in the closed loop of the rat small intestine. Biol Pharm Bull 28 (2005), 553–555.
31. [31] Maeda, N., Funahashi, T., Shimomura, I., Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9. Nat Clin Pract Endocrinol Metab 4 (2008), 627–634.
32. [32] Crescenzo, R., Bianco, F., Mazzoli, A., Giacco, A., Liverini, G., Iossa, S., A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance. Eur J Nutr 55 (2016), 1–6.
33. [33] Kim, J.A., Wei, Y., Sowers, J.R., Role of mitochondrial dysfunction in insulin resistance. Circ Res 102 (2008), 401–414.
34. [34] Dahlman, I., Forsgren, M., Sjogren, A., Nordstrom, E.A., Kaaman, M., Naslund, E., et al. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes 55 (2006), 1792–1799.
35. [35] Heinonen, S., Buzkova, J., Muniandy, M., Kaksonen, R., Ollikainen, M., Ismail, K., et al. Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes 64 (2015), 3135–3145.
36. [36] Satapati, S., Kucejova, B., Duarte, J.A., Fletcher, J.A., Reynolds, L., Sunny, N.E., et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest 125 (2015), 4447–4462.
37. [37] Petersen, K.F., Befroy, D.E., Dufour, S., Rothman, D.L., Shulman, G.I., Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by (13)C magnetic resonance spectroscopy. Cell Metab 24 (2016), 167–171.